Drugs with this side effect
- 5-ASA: 1% - 2%
- 5-FU
- 5-aza-2'-deoxycytidine: 13.1%
- 5-azacytidine: 9.78% - 16.4%
- Azarga
- Bivalirudin: postmarketing, 0.0012% - 1.9%
- CAS 76095-16-4
- CGP 19835A: common
- Cancidas
- Colimycin M
- Eptifibatide: 0.192%
- FAMP: 0% - 1%
- FK463: 0% - 16.7%
- FdUrd
- Glat copolymer: infrequent
- Goserelin: 1-10%
- Histrelin
- Insulin: 0.8% - 1.3%
- K779
- L-Dmp: infrequent
- Leuprorelin
- Lisinopril
- Lovaza
- Lutalyse
- MDV3100: 0.1% - 3.3%
- Meropenem anhydrous: 0.2%
- NTBC
- Nafarelin
- Octreotide: 0-2%
- PCI-32765
- Refludan: 0.6% - 4.4%
- Revasc
- Supremon
- Triptorelin
- UDCA
- Zyprexa Relprevv: uncommon
- acamprosate: infrequent
- acitretin: postmarketing
- afatinib: very common, 0% - 17%
- alfentanil
- aliskiren
- allopurinol
- almotriptan: rare
- alprazolam: infrequent
- ambrisentan: 1.54% - 5.97%
- amlodipine
- amlodipine besylate
- amphotericin B: 14.9% - 20.1%
- anagrelide: 1-5%
- apixaban: uncommon, common, 1.55% - 3.58%
- aripiprazole
- arsenic
- arsenic trioxide
- atenolol
- atorvastatin
- avanafil
- axitinib: 6% - 7.8%
- azelastine: 0.956% - 5.84%
- beclomethasone: 1.91%
- beclomethasone dipropionate
- betaxolol
- bexarotene
- bicalutamide
- boceprevir: common
- bortezomib: 10%
- bosentan: 2% - 5%
- brinzolamide: postmarketing
- bromfenac
- budesonide: 2% - 8%
- bupropion: rare, 1% - 2%
- buspirone: rare
- busulfan: 25%
- butorphanol
- cabergoline
- candesartan
- candesartan cilexetil
- capecitabine: 0.1% - 6%
- carboprost
- cefaclor: 0% - 2.04%
- cefpodoxime
- ceftriaxone: 0.1%
- celecoxib
- cerivastatin
- cetirizine: 1.9% - 3.7%
- cevimeline
- ciclesonide: 2.7% - 11.4%
- cidofovir
- cilazapril
- cilostazol
- ciprofloxacin: postmarketing
- citalopram: postmarketing, infrequent, uncommon
- cladribine: common, 5%
- clarithromycin
- clindamycin
- clindamycin phosphate
- clofarabine: common
- clomipramine: 2%
- clonazepam
- clonidine: 0% - 3%
- clopidogrel: very rare, postmarketing
- clozapine
- conjugated estrogens
- copolymer 1
- dabigatran etexilate
- dabrafenib
- dalteparin: 1.34% - 1.93%
- darunavir
- dasatinib
- deferiprone: postmarketing
- delavirdine
- deprenyl: rare
- desloratadine
- desmopressin: 0% - 3%
- desvenlafaxine
- diclofenac
- dihydroergotamine: rare
- diltiazem
- docetaxel: 0% - 5%
- dolasetron
- donepezil: infrequent
- dorzolamide: postmarketing
- doxazosin: 1%
- doxorubicin: common
- duloxetine
- eletriptan: rare
- entacapone
- eprosartan
- eribulin
- erlotinib
- ertapenem
- eslicarbazepine acetate
- esomeprazole magnesium
- estazolam: rare
- estradiol
- etoricoxib
- everolimus: common, very common, 0% - 22%
- febuxostat
- felbamate
- felodipine
- fentanyl
- ferumoxytol: postmarketing
- fexofenadine: 0.3% - 1.1%
- fludarabine: 0% - 1%
- flunisolide: 0% - 3.2%
- fluoxetine: infrequent, common
- flurbiprofen
- fluticasone: 3.99% - 6.9%
- fluticasone furoate: very common, 3.99% - 20.3%
- fluticasone propionate: very common, 1.6% - 13.3%
- fluvoxamine: rare, infrequent, 0% - 2%
- fondaparinux: uncommon, 1.09% - 1.31%
- fosinopril: uncommon
- fosinoprilat
- fosphenytoin: infrequent
- frovatriptan: infrequent
- gabapentin: infrequent
- gadolinium
- gadoversetamide
- galantamine: rare, infrequent
- gatifloxacin
- gefitinib: common, 0% - 11.3%
- gliclazide
- glycopyrrolate: uncommon
- granisetron
- hydrochlorothiazide
- hydroxybutyrate
- ibuprofen
- iloperidone
- iloprost: postmarketing
- imatinib: common, 0% - 13%
- indomethacin
- insulin detemir
- iopromide: postmarketing
- ipratropium bromide: 0.3% - 9%
- irbesartan: uncommon
- irbesartan-hydrochlorothiazide
- isosorbide-5-mononitrate
- ketoconazole
- ketoprofen
- ketorolac
- ketorolac tromethamine: postmarketing
- ketotifen
- labetalol: 1.6%
- lamivudine
- lamotrigine: infrequent, 0% - 2%
- lansoprazole
- lapatinib: very common, 0% - 2%
- leflunomide
- lenalidomide: postmarketing, common
- leuprorelin acetate
- levetiracetam
- lomefloxacin
- loratadine
- losartan
- medroxyprogesterone acetate
- memantine
- meropenem: 0.2%
- methotrexate
- methylphenidate
- metipranolol
- metolazone
- mirtazapine: infrequent
- misoprostol: postmarketing
- modafinil
- mometasone: 11%
- mometasone furoate
- montelukast: postmarketing
- moxifloxacin
- mupirocin
- mycophenolate mofetil
- mycophenolic acid
- nabilone
- naltrexone
- naproxen
- nefazodone: infrequent
- nelarabine: 0% - 8%
- nelfinavir: 0% - 2.56%
- nicorandil: uncommon
- nicotine
- nifedipine
- nilotinib: uncommon, common
- nisoldipine
- nitazoxanide
- ofloxacin
- olanzapine: infrequent, uncommon, 3%
- olopatadine: postmarketing, 1.69% - 3.24%
- omeprazole: postmarketing
- oseltamivir: 3.1% - 16%
- oxaliplatin: very common, 0% - 12%
- oxcarbazepine: 0% - 4%
- oxybutynin
- oxycodone
- paclitaxel: rare, common
- paliperidone: 0% - 2%
- palonosetron
- pantoprazole
- paricalcitol
- paroxetine: postmarketing, infrequent, uncommon
- pazopanib
- pentosan polysulfate
- pentoxifylline: postmarketing
- pergolide: infrequent, 1.6%
- perindopril
- perindopril erbumine
- phenytoin: infrequent
- pilocarpine
- pimecrolimus: 0% - 3.31%
- piperacillin
- piroxicam
- pomalidomide: 10.7% - 15%
- ponatinib
- posaconazole
- pralatrexate
- pramipexole
- prasugrel
- prazosin
- pregabalin: infrequent
- procarbazine
- propafenone
- prostacyclin
- pyridostigmine: 2%
- quetiapine: infrequent, 0% - 3%
- rabeprazole
- raltegravir
- ramipril
- ramiprilat
- ranolazine
- rapamycin: postmarketing, common, 1%
- rasagiline
- rasburicase
- reboxetine
- reserpine
- retinoic acid: postmarketing
- ribavirin: common
- rifapentine
- rifaximin
- riluzole: infrequent, uncommon
- riociguat
- risperidone: infrequent, 0.5% - 6%
- ritonavir
- rivaroxaban
- rivastigmine: frequent
- rizatriptan: infrequent
- rofecoxib
- ropinirole: infrequent, frequent
- rufinamide
- ruxolitinib: very common, 2.3% - 13.3%
- salbutamol: postmarketing, 1% - 3%
- salicylate
- salmeterol
- salmon calcitonin acetate: 3.5% - 4.6%
- samarium: 2.01%
- saquinavir
- sertraline: postmarketing, infrequent, uncommon
- sibutramine
- sildenafil: postmarketing, rare, 4% - 9%
- sitaxsentan: common, 3.36% - 7.99%
- sodium cromoglycate
- sorafenib
- sparfloxacin
- sulindac
- sumatriptan
- sunitinib
- tacrolimus
- tadalafil: postmarketing, 4%
- tamsulosin: postmarketing
- telmisartan
- temsirolimus
- terazosin
- thalidomide
- thiotepa
- tiagabine: frequent
- tiaprofenic acid: 0.1% - 1.4%
- ticagrelor
- ticlopidine
- tiotropium: 1% - 4%
- tipranavir: 3.7%
- tobramycin: common, 1.9% - 7%
- tolcapone: infrequent
- tolmetin: postmarketing
- topiramate: 0% - 8%
- topotecan
- tramadol: postmarketing, uncommon
- tramazoline
- trametinib
- trandolapril
- trandolaprilat
- treprostinil: 0.0904%
- triamcinolone: 2.7% - 11%
- triamcinolone acetonide: 0.885% - 19.4%
- trimethadione
- trimethoprim: very rare
- trovafloxacin
- v 1784: postmarketing
- valdecoxib
- valproate
- valsartan
- vandetanib
- vardenafil
- varenicline: frequent
- venlafaxine: infrequent
- vinflunine
- voriconazole
- warfarin
- zalcitabine
- zaleplon: 1%
- zidovudine
- zidovudine/lamivudine
- ziprasidone: infrequent
- zolmitriptan: infrequent
- zolpidem: rare
- zopiclone: infrequent
|
Drugs with this indication
|
